Skip navigation

Navigate Regulatory Hurdles and Leverage Medical Utility, Safety, and Efficacy Data to Advance Clinical Research

November 30-December 1, 2017
  • Denver, CO

Guy Chamberland
Chief Scientific Officer
Tetra Biopharma

Michael Chernis
Founder
Chernis Law Group P.C.

Jay Denniston
Director of Science
Dixie Elixirs and Edibles

Adrian Devitt-Lee
Senior Research Associate, CannaCraft, Inc.;
Contributing Writer, Project CBD

Lezli Engelking
Executive Director
Foundation of Cannabis Unified Standards (FOCUS)

Nick Etten
Executive Director
Veteran’s Cannabis Project

Rino Ferrarese
Chief Operating Officer
Connecticut Pharmaceutical Solutions

Brian J. Fisher
Vice President of Operations & Corporate Partnerships
The Sturge Weber Foundation

Bob Hoban
Director
Hoban Law Group

Sazzad Hossain
Founder & Chief Scientific Officer
InMed Pharmaceuticals

Nick Jikomes, PhD
Principal research Scientist
Leafly

Bill Kinney
President
IntraMed

Mikhail Kogan, MD
Medical Director, GW Center for Integrative Medicine, Assistant Professor of Medicine, Associate Director of Geriatric Fellowship
George Washington University

Martin A. Lee
Co-Founder & Director
Project CBD

Paul Lyons
Medical Director
Virginia Comprehensive Epilepsy Program

Richard Peet, JD, PhD
Executive Vice President, Chief Intellectual Property Counsel
Teewinot Life Sciences Corporation

Jeffrey Raber
Executive Director
Association of Commercial Cannabis Laboratories (ACCL)

Tom Schultz
President
Connecticut Pharmaceutical Solutions

Beatrice Setnik, PhD
VP, Scientific & Medical Affairs – Early Phase
INC Research / inVentiv Health

Marc Wayne
Founding President & Director
Canopy Health Innovations

Graham Wood
Executive Vice President, Phase I Clinical Development
Altasciences Clinical Research

Guy Chamberland
Chief Scientific Officer
Tetra Biopharma

Michael Chernis
Founder
Chernis Law Group P.C.

Jay Denniston
Director of Science
Dixie Elixirs and Edibles

Adrian Devitt-Lee
Senior Research Associate, CannaCraft, Inc.;
Contributing Writer, Project CBD

Lezli Engelking
Executive Director
Foundation of Cannabis Unified Standards (FOCUS)

Nick Etten
Executive Director
Veteran’s Cannabis Project

Rino Ferrarese
Chief Operating Officer
Connecticut Pharmaceutical Solutions

Brian J. Fisher
Vice President of Operations & Corporate Partnerships
The Sturge Weber Foundation

Bob Hoban
Director
Hoban Law Group

Sazzad Hossain
Founder & Chief Scientific Officer
InMed Pharmaceuticals

Nick Jikomes, PhD
Principal research Scientist
Leafly

Bill Kinney
President
IntraMed

Mikhail Kogan, MD
Medical Director, GW Center for Integrative Medicine, Assistant Professor of Medicine, Associate Director of Geriatric Fellowship
George Washington University

Martin A. Lee
Co-Founder & Director
Project CBD

Paul Lyons
Medical Director
Virginia Comprehensive Epilepsy Program

Richard Peet, JD, PhD
Executive Vice President, Chief Intellectual Property Counsel
Teewinot Life Sciences Corporation

Jeffrey Raber
Executive Director
Association of Commercial Cannabis Laboratories (ACCL)

Tom Schultz
President
Connecticut Pharmaceutical Solutions

Beatrice Setnik, PhD
VP, Scientific & Medical Affairs – Early Phase
INC Research / inVentiv Health

Marc Wayne
Founding President & Director
Canopy Health Innovations

Graham Wood
Executive Vice President, Phase I Clinical Development
Altasciences Clinical Research